Balyasny Asset Management’s CME Group CME Stock Holding History

Balyasny Asset Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,500	Closed	-$956K	–	2964
2025 Q4	$956K	Buy	3,500 +2,100	+150%	+$571K	﹤0.01%	2222
2025 Q3	$378K	Hold	1,400	–	–	﹤0.01%	2499
2025 Q2	$386K	Sell	1,400 -112,200	-99%	-$30.5M	﹤0.01%	2394
2025 Q1	$30.1M	Buy	+113,600	New	+$28M	0.05%	444
2023 Q2	–	Sell	-3,400	Closed	-$651K	–	2336
2023 Q1	$651K	Sell	3,400 -29,400	-90%	-$5.32M	﹤0.01%	1879
2022 Q4	$5.52M	Buy	32,800 +3,400	+12%	+$591K	0.02%	986
2022 Q3	$5.21M	Buy	29,400 +11,900	+68%	+$2.35M	0.02%	970
2022 Q2	$3.58M	Buy	+17,500	New	+$3.71M	0.01%	1090
2016 Q2	–	Sell	-120,000	Closed	-$11.5M	–	1196
2016 Q1	$11.5M	Buy	+120,000	New	+$10.9M	0.07%	358

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Balyasny Asset Management's CME Position: Q1 2026 in Review

Balyasny Asset Management increased its CME Group (CME) stake by 702% in Q1 2026, buying an estimated $121M and bringing the position to 464,624 shares worth $137M. The position accounts for 0.18% of the portfolio, ranked #113.

Balyasny Asset Management first reported a position in CME in Q2 2013 and has held it in 51 quarters since. The position peaked at $284M in Q3 2024. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Balyasny Asset Management held 464,624 shares of CME Group worth $137M as of Q1 2026.
Balyasny Asset Management bought 406,721 CME Group shares in Q1 2026, an estimated $121M.
CME Group made up 0.18% of Balyasny Asset Management's portfolio in Q1 2026, its #113 holding.
Balyasny Asset Management first reported a position in CME Group in Q2 2013 and has held it in 51 quarters since.
Balyasny Asset Management's CME Group position peaked at $284M in Q3 2024.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.